Navigation Links
Neuronascent to Present at Life Sciences Summit 2009
Date:9/15/2009

CLARKSVILLE, Md.., Sept. 15 /PRNewswire/ -- Neuronascent, Inc., a privately-held biotechnology company developing novel, neurogenic small-molecule drugs for the treatment of depression, Alzheimer's, Parkinson's and other neurodegenerative diseases, today announced that Dr. Judith Kelleher-Andersson, President and Chief Scientific Officer, will present at the Life Sciences Summit 2009 -- Showcasing Innovation, Promoting Collaboration. The Summit brings the world's leading companies together with the world's most innovative scientists to explore the next generation of biomedical solutions, the proceeds from which will help seed a bio-innovation research fund to support the discovery, development, translation, and commercialization of these new technologies. The event will take place on September 23-24, 2009 at Hyatt Regency Long Island in Hauppauge, New York.

"We are proud to have been selected to showcase the potential of our first-in-class CNS drug candidates and our neurogenesis platform," said Dr. Kelleher-Andersson. "Our participation in the Summit, with the nation's leading research institutions and top bioscience companies, supports our strategy for collaboration and innovation combining the best of business and the best of science."

About Neuronascent, Inc.:

Founded in 2004 by Dr. Judith Kelleher-Andersson, Neuronascent, discovers and develops first-in-class, small-molecule therapeutics, based on the science of neurogenesis, that target depression and neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The Company is headquartered in Clarksville, MD and has facilities in Rockville and Walkersville, MD. For additional information, please visit www.neuronascent.com.

About The Center for Biotechnology, A New York State Center for Advanced Technology in Medical Biotechnology:

The Center for Biotechnology is a cooperative research and development partnership between universities, private industry and New York State. Located on the campus of Stony Brook University, the Center's technology development initiative has contributed to an active pipeline of more than forty commercially promising technologies, the commercialization of more than a dozen novel biomedical products, and the formation of eighteen new bioscience companies. The Center is funded by the New York Office of Science, Technology and Academic Research (NYSTAR). Visit www.biotech.sunysb.edu for more information on the Center.


'/>"/>
SOURCE Neuronascent, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Martek to Present at Two Upcoming Investor Conferences
2. ViroPharma to Present at Four Additional Healthcare Conferences
3. Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17, 2009
4. ERT to Present at UBS Global Life Sciences Conference on September 21, 2009
5. Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
6. NovaBay(R) Presents Data Confirming Its Aganocide(R) Compounds Are Effective In Killing Bacteria That Have Developed Multidrug-Resistance
7. aTyr Pharma to Present at BioPharm America 2009
8. CryoLife to Present at UBS Global Life Sciences Conference
9. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting
10. Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference
11. Enox Biopharma Will Present Its Unique Self-Sterilizing Urinary Catheter at the 49th Annual ICAAC Meeting.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... research organization (CRO) has validated a 0.2 ng/mL lower limit (LLOQ) assay for ... a 0.5 ng/mL LLOQ assay, the ultra-low trace nicotine assay meets additional needs ...
(Date:4/27/2017)... ... April 27, 2017 , ... Mitotech S.A, a Luxembourg based clinical ... Neuropathy (LHON) patients. LHON is a rare devastating genetic disease that leads to a ... in a group of 20 patients carrying 11778, 14484 and 3460 mutations and having ...
(Date:4/27/2017)... ... April 27, 2017 , ... Sierra Instruments ... based on capillary thermal mass flow technology provide exponentially more accurate mass flow ... Over 80% of all industrial processes—such as those involving chemical reactions, combustion, respiration, ...
(Date:4/27/2017)...  Pendant Biosciences, Inc. (formerly Nanoferix, Inc.), a privately-held ... delivery technologies, today announced that it has been accepted ... Toronto . Shawn Glinter , ... "We are excited to become part of the JLABS ... honored to be the first Tennessee ...
Breaking Biology Technology:
(Date:3/22/2017)... LIVERMORE, Calif. , March 21, 2017 ... recognition analytics company serving law enforcement agencies, announced today ... Sheridan as director of public safety business development. ... of diversified law enforcement experience, including a focus on ... Vigilant. In his most recent position, Mr. Sheridan served ...
(Date:3/13/2017)... Future of security: Biometric Face Matching software  ... ... DERMALOGs Face Matching enables to match face pictures against each other or against ... (PRNewsFoto/Dermalog Identification Systems) ... Matching" is the fastest software for biometric Face Matching on the market. The ...
(Date:3/7/2017)... 7, 2017   HireVue , the leading provider ... identify the best talent, faster, today announced the additions ... (CSO) and Diana Kucer as Chief Marketing ... executive team poised to drive continued growth in the ... year of record bookings in 2017. "Companies ...
Breaking Biology News(10 mins):